7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with aripiprazole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Forbes, RA; Kikuchi, T; McQuade, RD; Tadori, Y | 1 |
Hoenicka, J; Jiménez-Arriero, MÁ; Martín-Palanco, NG; Palomo, T; Ponce, G; Quiñones-Lombraña, A; Rubio-Solsona, E | 1 |
2 other study(ies) available for 7-hydroxy-2-n,n-dipropylaminotetralin and aripiprazole
Article | Year |
---|---|
Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Mutation; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D3; Tetrahydronaphthalenes; Transfection | 2008 |
The Addiction-Related Gene Ankk1 is Oppositely Regulated by D1R- and D2R-Like Dopamine Receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Aripiprazole; Brain; Down-Regulation; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Quinolines; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Tetrahydronaphthalenes; Up-Regulation | 2016 |